Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article discusses the potential health benefits of pumpkin seed oil, highlighting its uses in heart wellness, skincare, bone health, hair growth, and more, but it reports no new clinical results.

This study found that tadalafil use was associated with a decreased risk of major adverse cardiac events and venous thromboembolism in men with lower urinary tract symptoms.

This study found that frailty independently raises the risk of clinical BPH progression and serious adverse events in older men, suggesting that shared decision-making is essential when considering medical therapy for frail patients.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

This study observed that multiphoton excitation microscopy revealed changes in vascular structure and hair papillae in mice subcutaneous tissue following cyclophosphamide treatment for chemotherapy-induced alopecia.

This paper introduces Concentration Growth Factor (CGF) as a potential treatment for androgenetic alopecia, but reports no clinical findings on its effectiveness in promoting hair growth.

This study reports that in aged mice, hair follicle dermal stem cells exhibit diminished self-renewal and preferential differentiation into dermal sheath cells, contributing to age-related hair loss.

Scalp advancement is a quick surgery for lowering high hairlines, especially in women with loose scalps.

This study observed that 21.6% of oncology patients experienced dermatological side effects from anti-cancer drugs, with hair loss and skin pigmentation changes being the most common.

This study observed that morbilliform rash was the most common adverse cutaneous drug reaction, and antimicrobials, particularly nevirapine, were the primary causative agents among patients in Rajkot, Gujarat.

This paper reviews the potential link between finasteride's adverse effects and factors like hand preference and sexual orientation, emphasizing the need for personalized therapeutic approaches in treating male androgenic alopecia.

There are now better methods for hair regrowth.

Hair restoration surgery is improving, with less painful techniques like FUE and robotic systems, but they can be costly and require training.

Finding solutions to hair loss problems is possible.

Finasteride can cause sexual side effects like decreased libido and erectile dysfunction.

This text is a website user interface and does not include an abstract summary or research findings.

The document lists dermatology job ads across the U.S. with good pay and benefits.

The document listed various medical job opportunities with competitive benefits and living conditions.

This abstract contains no research findings; it outlines website features and access options for the JAMA network's publications.

In this study, the use of finasteride in young patients may be linked to a higher risk of anxiety, depression, and suicide-related adverse events.

This review summarizes research advancements in the pathogenesis, diagnosis, evaluation, and treatment of androgenetic alopecia in 2020, but reports no new clinical findings.

Hair loss, not finasteride, is more strongly linked to psychological issues and suicidality.

Finasteride can cause gum swelling and bleeding, but stopping the drug helps recovery.

This review discusses the sexual side effects of long-term finasteride usage in men, noting varied reports of sexual dysfunction which typically improve over time; it presents no new experimental data.

This review discusses recent advances in Traditional Chinese Medicine treatments for androgenic alopecia, highlighting approaches such as syndrome differentiation, specialized formulas, and acupuncture, but reports no new clinical results.

This study found that STAT3 signaling is essential for initiating the hair growth phase but not involved in hair follicle development during the fetal period.

This review discusses advances in forensic DNA profiling, highlighting new genetic markers and methods for identifying unknown individuals, but reports no new research findings.

This review discusses the diagnosis and management of severe cutaneous adverse reactions to drugs and provides guidance for physicians to improve patient outcomes, but it reports no new clinical results.